Chardan Capital Markets: Chardan Capital Markets acts as Sole Placement Agent for PierianDx in its $9.25 Million Series A Financing

NEW YORK, Jan. 19, 2016 /PRNewswire/ -- PierianDx, the leading provider of genomic software and services to enable data-driven personalized medicine, announced that it closed $9.25 million in Series A financing. This financing will enable PierianDx to expand its lead as a pioneer in Next Generation Sequencing (NGS) software and services. PierianDx will use the funding to accelerate product development and expand sales, marketing and operations efforts.read more